|
Samuel Agus, M.D. Abbott Products Operations AG
Alberto Ascherio, M.D. Professor of Epidemiology and Nutrition Harvard School of Public Health
Debra Babcock, M.D., Ph.D. Program Director Extramural Research Program National Institute of Neurological Disorders and Stroke National Institutes of Health
Andrea Baruchin, Ph.D. Associate Director for NIH Initiatives Foundation for the National Institutes of Health
James Beck, Ph.D. Director of Research Programs Parkinson’s Disease Foundation
Debra Bergstrom, Ph.D. Program Analyst National Institute of Neurological Disorders and Stroke National Institutes of Health
Robert Bowser, Ph.D. Associate Professor University of Pittsburgh School of Medicine
Susan Bressman, M.D. Chair Department of Neurology Beth Israel Medical Center
David Brooks, M.D. Professor Imperial College London
Neil Buckholtz, Ph.D. Chief, Dementias of Aging Branch National Institute on Aging National Institutes of Health
David Burn, M.D. Professor Movement Disorder Neurology Newcastle University
Sohini Chowdhury, M.A. Acting Vice President, Research Programs Michael J. Fox Foundation for Parkinson’s Research
Lorraine Clark, Ph.D. Assistant Professor Columbia University
Thomas Comery Associate Director Pfizer
Carolyn Compton, M.D., Ph.D. Director Office of Biorepositories and Biospecimen Research National Cancer Institute National Institutes of Health
Ted Dawson, M.D., Ph.D. Professor Johns Hopkins University School of Medicine
David Eidelberg, M.D. Director Center for Neuroscience Feinstein Institute for Medical Research
Tatiana Foroud, Ph.D. Professor Indiana University
Mark Frasier, Ph.D. Associate Director and Team Leader, Research Programs Michael J. Fox Foundation for Parkinson’s Research
Brandy Fureman, Ph.D. Program Director, Channels, Synapses and Circuits National Institute of Neurological Disorders and Stroke National Institutes of Health
Wendy Galpern, Ph.D. Program Director, Clinical Trials National Institute of Neurological Disorders and Stroke National Institutes of Health
Xiang Gao, M.D., Ph.D. Instructor and Associate Epidemiologist Harvard Medical School
David Goldstein, M.D., Ph.D. Clinical Neurocardiology Section National Institute of Neurological Disorders and Stroke National Institutes of Health
Amelie Gubitz, Ph.D. Program Director National Institute of Neurological Disorders and Stroke National Institutes of Health
Katrina Gwinn, M.D. Scientific Officer National Institute of Neurological Disorders and Stroke National Institutes of Health
Mark Hallett, M.D. Chief, Human Motor Control Section Medical Neurology Branch National Institute of Neurological Disorders and Stroke National Institutes of Health
Franz Hefti, Ph.D. Avid Radiopharmaceuticals, Inc.
Steve Hersch, M.D., Ph.D. Associate Professor Massachusetts General Hospital Harvard Medical School
Un Jung Kang, M.D. Professor University of Chicago
Petra Kaufmann, M.D. Director, Clinical Research National Institute of Neurological Disorders and Stroke National Institutes of Health
Karl Kieburtz, M.D. Director, Center for Human Experimental Therapeutics University of Rochester
Louis Kirby, M.D. Co-Chair, Biomarkers Working Groups Coalition Against Major Diseases
|
Walter Koroshetz, M.D. Deputy Director National Institute of Neurological Disorders and Stroke National Institutes of Health
Rainer Kuhn, Ph.D. Head, Neurodegeneration Novartis
Story Landis, Ph.D. Director National Institute of Neurological Disorders and Stroke National Institutes of Health
Blair Leavitt, M.D. Neurologist and Associate Professor in Medical Genetics Centre for Molecular Medicine and Therapeutics University of British Columbia
James Leverenz, M.D. Associate Professor Veterans Administration Puget Sound Health Care System University of Washington
Karen Marder, M.D. Professor of Neurology Columbia-Presbyterian Medical Center Columbia University
Ken Marek, M.D. Senior Scientist Institute for Neurodegenerative Disorders
William Matthew, Ph.D. Director, Office of Translational Research National Institute of Neurological Disorders and Stroke National Institutes of Health
Tom Montine, M.D., Ph.D. Alvord Endowed Chair in Neuropathology and Professor of Pathology University of Washington
Wolfgang Oertel, M.D. Professor of Neurology Philipps-Universitat Marburg
Creighton Phelps, Ph.D. Program Director, Alzheimer’s Centers National Institute on Aging National Institutes of Health
Bernard Ravina, M.D. Associate Professor University of Rochester
Ian Reynolds, Ph.D. Director Merck Research Laboratories
Alexander Runko, Ph.D. Program Analyst National Institute of Neurological Disorders and Stroke National Institutes of Health
Clemens Scherzer, M.D. Associate Neurologist Brigham and Women’s Hospital
Mya Schiess, M.D. Professor University of Texas Medical School at Houston
Peter Schmidt, Ph.D. Chief Information Officer and Program Director National Parkinson Foundation
Mark Shearman, Ph.D. Vice President Neurodegeneration Research EMD Serono Research Institute
Todd Sherer, Ph.D. Acting Chief Executive Officer Michael J. Fox Foundation for Parkinson’s Research
Ira Shoulson, M.D. Professor University of Rochester
Beth-Anne Sieber, Ph.D. Program Officer National Institute of Neurological Disorders and Stroke National Institutes of Health
Andrew Singleton, Ph.D. Laboratory of Neurogenetics National Institute on Aging National Institutes of Health
Thierry Sornasse, Ph.D. Director, Biomarker Integration Elan Pharmaceuticals, Inc.
David Standaert, M.D., Ph.D. Professor University of Alabama at Birmingham
Margaret Sutherland, Ph.D. Program Director National Institute of Neurological Disorders and Stroke National Institutes of Health
Carlie Tanner, M.D., Ph.D. Clinical Research Director Parkinson’s Institute
Anna Taylor, Ph.D. Health Program Specialist National Institute of Neurological Disorders and Stroke National Institutes of Health
John Trojanowski, M.D., Ph.D. Director, University of Pennsylvania Institute on Aging Director, Udall Center University of Pennsylvania School of Medicine
David Vaillancourt, Ph.D. Associate Professor University of Illinois at Chicago
David Weiner, M.D. Head of Early Development and Neurodegenerative Diseases Research EMD Serono, Inc.
Janet Woodcock, M.D. Director Center for Drug Evaluation and Research U.S. Food and Drug Administration
Jing Zhang, Ph.D. Associate Professor University of Washington
|